We are live on ! Find out more
AGP

Artia Global Partners Portfolio holdings

AUM $542M
1-Year Est. Return 206.64%
This Fund
S&P 500
This Quarter Est. Return
+5.43%
1 Year Est. Return
+206.64%
3 Year Est. Return
+724.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$241M
AUM Growth
-$49.5M
Cap. Flow
-$56.8M
Cap. Flow %
-23.61%
Top 10 Hldgs %
81.6%
Holding
34
New
–
Increased
3
Reduced
3
Closed
7

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$5.15M
2
ARGX icon
argenx
ARGX
+$1.37M
3
ROIV icon
Roivant Sciences
ROIV
+$1.01M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$14.9M
2
MRNA icon
Moderna
MRNA
+$10.3M
3
IMGN
Immunogen Inc
IMGN
+$10.3M
4
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$9.63M
5
APLS
Apellis Pharmaceuticals
APLS
+$9.38M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMEA icon
26
Biomea Fusion
BMEA
$140M
$350K 0.15%
25,452
– –
GRTS
27
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$164K 0.07%
95,170
– –
APLS
28
DELISTED
Apellis Pharmaceuticals
APLS
– –
-102,940
Closed -$9.38M
BIIB icon
29
Biogen
BIIB
$31.4B
– –
-52,275
Closed -$14.9M
BNTX icon
30
BioNTech
BNTX
$24.8B
– –
-37,108
Closed -$4.01M
MRNA icon
31
Moderna
MRNA
$56B
– –
-84,719
Closed -$10.3M
MOR
32
DELISTED
MorphoSys AG American Depositary Shares
MOR
– –
-43,499
Closed -$325K
IMGN
33
DELISTED
Immunogen Inc
IMGN
– –
-543,358
Closed -$10.3M
ISEE
34
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-244,861
Closed -$9.63M
1
2

Similar funds

CA
CV Advisors Aventura, Florida $542M AUM 24.89% 1-Year Est. Return
WCM
Westerly Capital Management San Francisco, California $542M AUM 48.48% 1-Year Est. Return
LI
Louisbourg Investments Dieppe, New Brunswick, Canada $542M AUM 21.44% 1-Year Est. Return
CWWM
Clear Wave Wealth Management Red Bank, New Jersey $541M AUM
FVCM
F&V Capital Management Boca Raton, Florida $542M AUM 46.38% 1-Year Est. Return
LI
Lafayette Investments Ashton, Maryland $542M AUM 22.5% 1-Year Est. Return
CCT
Chemung Canal Trust Elmira, New York $541M AUM 32.42% 1-Year Est. Return
MFS
Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return

Artia Global Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Artia Global Partners held 34 positions worth $241M, down 17% from $290M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Artia Global Partners withdrew a net $56.8M in Q3 2023, closing 7 positions and reducing 3 holdings. Its most notable exit was Biogen, an estimated $14.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Artia Global Partners added an estimated $5.15M to Eli Lilly.

  • Artia Global Partners added most to Eli Lilly in Q3 2023, an estimated $5.15M increase.
  • Artia Global Partners's biggest Q3 2023 reduction was Sarepta Therapeutics, cutting an estimated $2.26M.
  • Artia Global Partners fully exited Biogen in Q3 2023, selling an estimated $14.9M.
  • Artia Global Partners's ten largest holdings make up 82% of its $241M portfolio in Q3 2023.
  • Artia Global Partners opened 0 new positions and closed 7 in Q3 2023.
  • Artia Global Partners's portfolio value fell 17% quarter-over-quarter to $241M.

Based on Artia Global Partners's 13F filing for Q3 2023, filed 14 Nov 2023.